Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001209191-23-016454

Options or other derivatives

  • Director acquired 2,082 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
JEFFS ROGER Director 2023-03-02 Grant or award · Stock Option (Right to Buy) +2,082 2,082 D
Loading xslF345X03/doc4.xml…